Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Framycetin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.92 |
| ▸ | RECQL | P46063 | 1/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.92 |
| ▸ | LRAT | O95237 | 2/20 | 0.84 |
| ▸ | MEN1 | O00255 | 1/20 | 0.84 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Framycetin SCHEMBL2133931 | 0.97 | BLM (0.98) | BLMRECQLTDP1LRATMEN1 | |
| Framycetin SCHEMBL285111 | 0.97 | BLM (0.98) | BLMRECQLTDP1LRATMEN1 | |
| Framycetin SCHEMBL29628935 | 0.97 | BLM (0.98) | BLMRECQLTDP1LRATMEN1 | |
| Framycetin SCHEMBL2133938 | 0.97 | BLM (0.98) | BLMRECQLTDP1LRATMEN1 | |
| Framycetin SCHEMBL373681 | 0.97 | BLM (0.98) | BLMRECQLTDP1LRATMEN1 | |
| Framycetin SCHEMBL3696748 | 0.97 | BLM (0.98) | BLMRECQLTDP1LRATMEN1 | |
| Paromomycin SCHEMBL3355 | 0.96 | BLM (1.00) | BLMRECQLTDP1LRATMEN1 | |
| Paromomycin SCHEMBL691558 | 0.96 | BLM (1.00) | BLMRECQLTDP1LRATMEN1 | |
| Paromomycin SCHEMBL2527138 | 0.96 | BLM (1.00) | BLMRECQLTDP1LRATMEN1 | |
| Paromomycin SCHEMBL1680052 | 0.96 | BLM (1.00) | BLMRECQLTDP1LRATMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10278 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005954-A | Antioxidant and antibacterial sexual collagen repair film | 山东博达医疗用品股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260103492-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2026-04-16 | — | — | US | claimed |
| US-20250367139-A1 | COMPOUND HYDROCORTISONE AND NEOMYCIN SULFATE GRANULE AND PREPARATION METHOD THEREOF | HEBEI CHANGTIAN PHARMACEUTICAL CO LTD (CN) | 2025-12-04 | — | — | US | claimed |
| US-20250312046-A1 | LIGATION CLIP AND PREPARATION METHOD THEREOF | SICHUAN GUONA TECHNOLOGY CO., LTD. (CN) | 2025-10-09 | — | — | US | claimed |
| EP-4628110-A1 | LIGATING CLIP | Chengdu Guona Technology Co., Ltd (CN) | 2025-10-08 | — | — | EP | claimed |
| US-12421281-B2 | Cyclosporine compositions and methods of use | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2025-09-23 | — | — | US | claimed |
| US-20250277175-A1 | SINGLE-CHAMBER MICROBIAL ELECTROLYSIS CELL SYSTEM WITHOUT ION EXCHANGE MEMBRANE AND METHOD FOR PRODUCING CLEAN GAS SUCH AS HYDROGEN AND BIOGAS USING SAME | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2025-09-04 | — | — | US | claimed |
| US-20250268978-A1 | TOPICAL CREAM AND METHOD OF USE | WellSpring and Company LLC (US) | 2025-08-28 | — | — | US | claimed |
| EP-3876904-B1 | ORAL MUCOSAL CARRIER AND PROTECTANT | INSPIRED MAT STRATEGIES LLC (US) | 2025-08-20 | — | — | EP | claimed |
| US-20250248940-A1 | Biopolymer Formulations for Drug Delivery | 11584022 CANADA INC. (CA) | 2025-08-07 | — | — | US | claimed |
| US-4136173-A | VEHICLES FOR OPHTHALMIC DRUGS | AMERICAN HOME PRODUCTS CORP. (US) | 1979-01-23 | — | — | US | claimed |
| US-4122158-A | FOR TREATMENT OF BURNS; BIODEGRADABLE HYDROPHOBIC POLYMER; SUSTAINED RELEASE | ALZA CORPORATION (US) | 1978-10-24 | — | — | US | claimed |
| US-4100271-A | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes | COOPER LABORATORIES, INC. (US) | 1978-07-11 | — | — | US | claimed |
| US-4035146-A | CELLULOSE, STARCHES, LEATHER | SCHWARZ SERVICES INTERNATIONAL LTD. (US) | 1977-07-12 | — | — | US | claimed |
| US-4024871-A | POLYURETHANE | ETHICON, INC. (US) | 1977-05-24 | — | — | US | claimed |
| US-4013792-A | BETAMETHASONE BENZOATE AND NEOMYCIN SULFATE IN ALCOHOLCELLULOSE-SODIUM CHLORIDE GEL | WARNER-LAMBERT COMPANY (US) | 1977-03-22 | — | — | US | claimed |
| US-3987797-A | ANTIMICROBIAL SUTURES | ETHICON, INC. (US) | 1976-10-26 | — | — | US | claimed |
| US-3983209-A | HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME | ALZA CORPORATION (US) | 1976-09-28 | — | — | US | claimed |
| US-3980778-A | Anti-inflammatory steroid | THE UPJOHN COMPANY (US) | 1976-09-14 | — | — | US | claimed |
| US-3949077-A | PRIMYCIN, NEOMYCIN SULFATE, OXYTETRACYCLINE | CHINOIN GYOGYSZER-ES VEGYESZETI TERMEKEK GYARA RT (HU) | 1976-04-06 | — | — | US | claimed |